PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of the Philippines Manila, Ermita, Manila, Philippines.\', \'Clover Biopharmaceuticals, Cambridge, MA, USA.\', \'Duke University Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.\', \'Oxford Vaccine Group, University of Oxford, Oxford, UK.\', \'Manila Doctors Hospital, Manila, Philippines.\', \'Asian Hospital and Medical Center, Alabang, Muntinlupa, Philippines.\', \'Global Research in Infectious Diseases, Singapore.\', \'Centro de Estudios en Infectología Pediátrica, Universidad Del Valle Clínica Imbanaco, Cali, Colombia.\', \'Clinica De La Costa, Barranquilla, Atlantico, Colombia.\', \'Hospital Universidad del Norte, Barranquilla, Colombia.\', \'Center of Attention in Medical Research, Bogotá, Colombia.\', \'Faculty of Health Sciences at the University of Caldas, Manizales, Colombia.\', \'Policlínico Social del Norte, Bogotá, Colombia.\', \'Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.\', \'D\'Or Institute for Research and Education, Rio de Janeiro, Brazil.\', \'Federal University of Rio Grande do Norte, Natal, Brazil.\', \'Infectious Diseases Division, Universidade Federal de Santa Maria, Rio Grande do Sul, Brazil.\', \'Atena Institute of Clinical Research, Rio Grande do Norte, Natal, Brazil.\', \'University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines.\', \'Far Eastern University Hospital - Nicanor Reyes Medical Foundation, Quezon City, Philippines.\', \'Las Pinas Doctors Hospital, Las Pinas City, Philippines.\', \'De La Salle Medical and Health Sciences Institute, Cavite City, Philippines.\', \'Tropical Disease Foundation, Cavite City, Philippines.\', \'Infection Control Service, St Luke\'s Medical Center, Taguig, Philippines.\', \'Anima Research Center, Alken, Belgium.\', \'Clinic of Infectious Diseases, CUB-Hôpital Erasme, Bruxelles, Belgium.\', \'Pulmonology Department, CHU Universite Catholique de Louvain Namur Site Sainte-Elisabeth, Namur, Belgium.\', \'Soweto Clinical Trials Centre, Johannesburg, South Africa.\', \'Wits Clinical Research, Soweto, Johannesburg, South Africa.\', \'DJW Research, Noordheuwel, Krugersdorp, Gauteng, South Africa.\', \'Dr JM Engelbrecht Trial Site, Vergelegen Mediclinic, Western Cape, South Africa.\', \'Independent Advisor, Stuart, FL, USA.\', \'Division of Paediatrics, University of Western Australia, Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute and Perth Children\'s Hospital, Perth, WA, Australia.\', \'Independent Advisor, New York, NY, USA.\', \'Clover Biopharmaceuticals, Chengdu, China.\', \'Global Research in Infectious Diseases, Rio de Janeiro, Brazil. Electronic address: clemens.ralf@outlook.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(22)00055-110.1016/S0140-6736(22)00055-1
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 35065705
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all